Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.95
ENvue Medical, Inc. entered into Securities Purchase Agreement with institutional investor valued at 180,000 shares common stock, pre-funded warrants for 2,726,977 shares, A-1 Warrants for 2,906,977 sh (effective 2023-08-30).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- institutional investor
- Value
- 180,000 shares common stock, pre-funded warrants for 2,726,977 shares, A-1 Warrants for 2,906,977 sh
- Effective
- 2023-08-30
Exact text from the filing
On August 30, 2023, NanoVibronix, Inc. (the “ Company ”) entered into a securities purchase agreement (the “ Purchase Agreement ”) with an institutional investor for the issuance and sale in a private placement (the “ Private Placement ”) of 180,000 shares (the “ Common Shares ”) of common stock, par value $0.001 per share (the “ Common Stock ”) , pre-funded warrants (“ Pre-Funded Warrants ”) to purchase up to 2,726,977 shares of common stock, with an exercise price of $0.0001 per share, A-1 Warrants (the “ A-1 Warrants ”) to purchase up to 2,906,977 shares of Common Stock, with an exercise price of $1.47 per share, and A-2 Warrants (the “ A-2 Warrants ” and together with the A-1 Warrants, the “ Warrants” ) to purchase up to 2,906,977 shares of Common Stock with an exercise price of $1.47 per share.
View on SEC.gov